Memantine Market to Reflect Steady Growth During 2018 – 2026
The drug received European marketing approval in 2002 and the U.S. Food and Drug Administration (U.S FDA) approval in 2003. The generic versions of the drugs are available since 2015.
The drug received European marketing approval in 2002 and the U.S. Food and Drug Administration (U.S FDA) approval in 2003. The generic versions of the drugs are available since 2015.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Memantine</strong> <strong>Market</strong> -<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,<br />
AND OPPORTUNITY ANALYSIS, <strong>2018</strong>-<strong>2026</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Memantine</strong> <strong>Market</strong> <strong>–</strong> Overview<br />
Increasing number of pipeline studies for use of memantine are expected <strong>to</strong> boost growth of the memantine<br />
market. For instance, in September 2016, Lille University Hospital started phase I clinical study for assessing<br />
the effects of memantine on cognitive behavior of patients associated with Alzheimer’s disease. The study is<br />
estimated <strong>to</strong> be completed by February 2019.<br />
Furthermore, Suven Life Sciences Limited is undergoing phase II clinical study for the comparative study on<br />
safety and efficacy of SUVN-502 along with memantine HCl and donezepil HCl for treating moderate<br />
Alzheimer’s disease. The study was started in September 2015 and is expected <strong>to</strong> be completed in May 2019.<br />
Increasing number of expired patents of drugs is a major fac<strong>to</strong>r hindering growth of the global memantine<br />
market. For instance, according Merz Pharmaceuticals, a Germany-based company, in Oc<strong>to</strong>ber <strong>2018</strong>, overall<br />
licensing income during patented period for memantine decreased due <strong>to</strong> expiration of patent protection in a<br />
majority of markets. For instance, according <strong>to</strong> Merz Pharmaceuticals, the U.S. licensing income for<br />
memantine declined <strong>to</strong> US$ 138.07 million in 2017-18 compared <strong>to</strong> US$ 183.34 million in year 2016.<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Memantine</strong> <strong>Market</strong> : Regional Analysis<br />
North America is expected <strong>to</strong> hold dominant position in the global memantine market, owing <strong>to</strong> increasing<br />
number of generic versions of memantine in the U.S. market. For instance, in February <strong>2018</strong>, Lupin Limited<br />
announced the launch of its <strong>Memantine</strong> Hydrochloride Extended-Release Capsules in the U.S. market. The<br />
capsules are available in 7mg, 14mg, 21mg, and 28mg, for which company has received an approval from<br />
the U.S. FDA. These are indicated for the treatment of moderate <strong>to</strong> severe dementia of the Alzheimer’s<br />
disease.<br />
Furthermore, Asia Pacific is expected <strong>to</strong> witness significant growth in the global memantine market, owing<br />
<strong>to</strong> increasing focus of key players in manufacturing memantine tablets. For instance, in Oc<strong>to</strong>ber <strong>2018</strong>, Dr.<br />
Reddy’s Labora<strong>to</strong>ries launched memantine hydrochloride tablets in the Indian market. They are available in<br />
5mg and 10mg, equivalent <strong>to</strong> generic version of Namenda tablets, which were already available in the U.S.<br />
market in July 2015.<br />
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2255<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Memantine</strong> <strong>Market</strong>: Key Players<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Merz Pharmaceuticals<br />
Lupin Limited<br />
Allergan<br />
Novartis AG<br />
Daiichi Sankyo Company<br />
Ono Pharmaceutical<br />
Eisai<br />
View this report @<br />
https://www.coherentmarketinsights.com/ongoing-insight/memantine-market-2255<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting organization<br />
focused on assisting its plethora of clients achieve transformational growth by helping<br />
them make critical business decisions. We are headquartered in India, with an office at<br />
the global financial capital in the U.S. Our client base includes players from across all<br />
business verticals in over 150 countries worldwide. We are uniquely positioned <strong>to</strong> help<br />
businesses around the globe deliver practical and lasting results through various<br />
recommendations about operational improvements, technologies, emerging market<br />
trends and new working methods. We offer both cus<strong>to</strong>mized and syndicated market<br />
research reports that help our clients create visionary growth plans <strong>to</strong> provide traction <strong>to</strong><br />
their business. We meticulously study emerging trends across various industries at both<br />
the global and regional levels <strong>to</strong> identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
SECTOR COVERAGE<br />
Healthcare<br />
CLINICAL DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality and Fine Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic Ingredients<br />
Polymers & Resins<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
Insights Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEARC<br />
H<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts and Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and<br />
food & beverages, <strong>to</strong> name a few. We implement holistic market research methodology in order <strong>to</strong> result in the best possible market research reports across<br />
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our<br />
clients achieve better outcomes with uniquely designed and highly cus<strong>to</strong>mized solutions. Our coverage includes insights that help our clients ensure sustained<br />
growth in developed markets and also key inputs <strong>to</strong> help them tap in<strong>to</strong> emerging markets and exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us, v isit o ur web site:<br />
www.coh er en tmark etinsig hts.com<br />
For sales q ueries o r new <strong>to</strong>p ics email u s o n :<br />
sales@coh er en tmark etinsig hts.co m<br />
Fo r o th er q uer ies co n tact:<br />
Mr. Sh ah<br />
( Man ag er - Business Dev elo pment)<br />
Co herent Mark et Insig hts<br />
sales@coh er en tmark etinsig hts.co m<br />
+1 -2 06 -7 0 1- 67 02<br />
THANK YOU<br />
© Coherent market Insights. All Rights Reserved
Change language